Polygenic risk score improves prostate cancer risk prediction: Results from the Stockholm-1 cohort study

European Urology

Volumn 60, Issue 1, 2011, Pages 21-28

  Aly, Markus ^a,b   Wiklund, Fredrik ^a   Xu, Jianfeng ^c   Isaacs, William B ^d   Eklund, Martin ^a   D'Amato, Mauro ^a   Adolfsson, Jan ^a   Grönberg, Henrik ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Diagnosis; Polygenic; Prediction model; Prostate cancer; SNP

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CHROMOSOME 19Q; CHROMOSOME 22Q; CHROMOSOME 2Q; CHROMOSOME 8Q; COHORT ANALYSIS; CONTROLLED STUDY; FAMILY HISTORY; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYGENIC RISK SCORE; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; QUESTIONNAIRE; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR BIOPSY;

AGED; COHORT STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIFACTORIAL INHERITANCE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROSTATIC NEOPLASMS; RISK ASSESSMENT; SWEDEN;

EID: 79957946061     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2011.01.017     Document Type: Article

References (24)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. J. Adolfsson, H. Garmo, and E. Varenhorst Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005 Scand J Urol Nephrol 41 2007 456 477 (Pubitemid 350207540)
3. J. Morote, E. Trilla, and S. Esquena The percentage of free prostatic-specific antigen is also useful in men with normal digital rectal examination and serum prostatic-specific antigen between 10.1 and 20 ng/ml Eur Urol 42 2002 333 337 (Pubitemid 35175793)
4. A.A. Al Olama, Z. Kote-Jarai, and G.G. Giles Multiple loci on 8q24 associated with prostate cancer susceptibility Nat Genet 41 2009 1058 1060
5. R.A. Eeles, Z. Kote-Jarai, and A.A. Al Olama Identification of seven new prostate cancer susceptibility loci through a genome-wide association study Nat Genet 41 2009 1116 1121
6. R.A. Eeles, Z. Kote-Jarai, and G.G. Giles Multiple newly identified loci associated with prostate cancer susceptibility Nat Genet 40 2008 316 321 (Pubitemid 351311772)
7. J. Gudmundsson, P. Sulem, and D.F. Gudbjartsson Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility Nat Genet 41 2009 1122 1126
8. J. Gudmundsson, P. Sulem, and T. Rafnar Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer Nat Genet 40 2008 281 283 (Pubitemid 351311771)
9. G. Thomas, K.B. Jacobs, and M. Yeager Multiple loci identified in a genome-wide association study of prostate cancer Nat Genet 40 2008 310 315 (Pubitemid 351311773)
10. S.L. Zheng, V.L. Stevens, and F. Wiklund Two independent prostate cancer risk-associated loci at 11q13 Cancer Epidemiol Biomarkers Prev 18 2009 1815 1820
11. L.T. Amundadottir, P. Sulem, and J. Gudmundsson A common variant associated with prostate cancer in European and African populations Nat Genet 38 2006 652 658 (Pubitemid 43927306)
12. GudmundssonJ, P. Sulem, and V. Steinthorsdottir Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes Nat Genet 39 2007 977 983 (Pubitemid 47185170)
13. J. Sun, S.L. Zheng, and F. Wiklund Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12 Nat Genet 40 2008 1153 1155
14. J. Sun, S.L. Zheng, and F. Wiklund Sequence variants at 22q13 are associated with prostate cancer risk Cancer Res 69 2009 10 15
15. J. Gudmundsson, P. Sulem, and A. Manolescu Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24 Nat Genet 39 2007 631 637 (Pubitemid 46676102)
16. S.L. Zheng, J. Sun, and F. Wiklund Cumulative association of five genetic variants with prostate cancer N Engl J Med 358 2008 910 919 (Pubitemid 351397090)
17. J.F. Ludvigsson, P. Otterblad-Olausson, B.U. Pettersson, and A. Ekbom The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research Eur J Epidemiol 24 2009 659 667
18. T. Hastie, R. Tibshirani, and J. Friedman The elements of statistical learning ed 2 2009 Springer New York, NY
19. M.J. Pencina, R.B. D'Agostino Sr., R.B. D'Agostino Jr., and R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172 discussion 207-12 (Pubitemid 351193639)
20. R. Newson Confidence intervals for rank statistics: Somers' D and extensions Stata J 6 2006 309 334 (Pubitemid 44505049)
21. L.E. Johns, and R.S. Houlston A systematic review and meta-analysis of familial prostate cancer risk BJU Int 91 2003 789 794 (Pubitemid 36724060)
22. P.D. Pharoah, A. Antoniou, M. Bobrow, R.L. Zimmern, D.F. Easton, and B.A. Ponder Polygenic susceptibility to breast cancer and implications for prevention Nat Genet 31 2002 33 36
23. F. Wiklund Prostate cancer genomics: can we distinguish between indolent and fatal disease using genetic markers? Genome Med 2 2010 45
24. A.E. Guttmacher, A.L. McGuire, B. Ponder, and K. Stefansson Personalized genomic information: preparing for the future of genetic medicine Nat Rev Genet 11 2010 161 165